BR9907150A - Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol - Google Patents

Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol

Info

Publication number
BR9907150A
BR9907150A BR9907150-9A BR9907150A BR9907150A BR 9907150 A BR9907150 A BR 9907150A BR 9907150 A BR9907150 A BR 9907150A BR 9907150 A BR9907150 A BR 9907150A
Authority
BR
Brazil
Prior art keywords
miconazole nitrate
vulvovaginal candidiasis
kits
methods
pharmaceutically acceptable
Prior art date
Application number
BR9907150-9A
Other languages
English (en)
Portuguese (pt)
Inventor
David H Upmalis
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22727682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9907150(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of BR9907150A publication Critical patent/BR9907150A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9907150-9A 1998-11-20 1999-11-15 Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol BR9907150A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/197,019 US6153635A (en) 1998-11-20 1998-11-20 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
PCT/US1999/027091 WO2000030626A2 (en) 1998-11-20 1999-11-15 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate

Publications (1)

Publication Number Publication Date
BR9907150A true BR9907150A (pt) 2000-10-24

Family

ID=22727682

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907150-9A BR9907150A (pt) 1998-11-20 1999-11-15 Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol

Country Status (13)

Country Link
US (1) US6153635A (https=)
EP (1) EP1051162B1 (https=)
JP (1) JP2002530327A (https=)
KR (1) KR100701490B1 (https=)
CN (1) CN1332663C (https=)
AR (1) AR021863A1 (https=)
AU (1) AU777508B2 (https=)
BR (1) BR9907150A (https=)
CA (1) CA2318125C (https=)
DE (1) DE69930725T2 (https=)
ES (1) ES2262353T3 (https=)
TW (1) TWI229599B (https=)
WO (1) WO2000030626A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
EP1500394A1 (en) * 2003-07-22 2005-01-26 Polichem S.A. Pharmaceutical compositions comprising ascorbic acid or the treatment of fungal superinfections and fungal recurrences
CA2538991A1 (en) 2003-09-18 2005-03-31 Children's Medical Center Corporation Treatment of severe distal colitis
US20070065504A1 (en) * 2004-03-23 2007-03-22 Lin Shun Y Products and methods for treating vaginal infections
US20050214364A1 (en) * 2004-03-23 2005-09-29 Hutman Herbert W Products and methods for treating vaginal infections
US8057433B2 (en) 2004-07-08 2011-11-15 Drugtech Corporation Delivery system
US20090156987A1 (en) * 2007-12-14 2009-06-18 Mclean Barbara Wanamaker Apparatus and method of delivery of substances into target tissue
WO2018013625A1 (en) * 2016-07-13 2018-01-18 Concert Pharmaceuticals, Inc. Deuterated miconazole
JP2025507426A (ja) * 2022-02-17 2025-03-18 ゼンビジョン ファルマ エルエルピー ミコナゾール及びルリコナゾール又はそれらの塩を含む膣用医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
KR20010034150A (ko) 2001-04-25
ES2262353T3 (es) 2006-11-16
EP1051162A1 (en) 2000-11-15
WO2000030626A2 (en) 2000-06-02
AU2024800A (en) 2000-06-13
TWI229599B (en) 2005-03-21
CA2318125A1 (en) 2000-06-02
WO2000030626A3 (en) 2000-11-23
CN1332663C (zh) 2007-08-22
KR100701490B1 (ko) 2007-04-02
EP1051162B1 (en) 2006-04-05
CN1288379A (zh) 2001-03-21
CA2318125C (en) 2005-03-08
AU777508B2 (en) 2004-10-21
US6153635A (en) 2000-11-28
DE69930725D1 (de) 2006-05-18
DE69930725T2 (de) 2007-04-12
AR021863A1 (es) 2002-08-07
HK1036930A1 (zh) 2002-01-25
JP2002530327A (ja) 2002-09-17

Similar Documents

Publication Publication Date Title
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0005276A (pt) Compostos para o tratamento de disfução sexual feminina
BR9916076A (pt) Composição adequada para aplicação tópica, uso de uma composição tópica métodos para melhorar o distúrbio do estìmulo sexual feminino, e para intensificar o estìmulo sexual feminino, e a resposta sexual feminina, artigo de manufatura
CA2213339A1 (en) Method of treating adenosine depletion
EA199700437A1 (ru) Микроинкапсулированные лактобациллы для медицинского применения
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
BRPI0411319A (pt) compostos terapeuticamente ativos e sua utilização
EP0655914A4 (en) NEW COMPOSITIONS.
PL310474A1 (en) Application of rilusole in treating neuro-aids diseases
ES2177581T3 (es) Uso de compuestos de piperidina en el tratamiento de esquizofrenia.
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
BR9907150A (pt) Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol
BR0112659A (pt) Processo para o tratamento de secura vaginal ou disfunção sexual em mulheres durante ou depois da menopausa e utilização do composto (diaminoidroxi)toremifeno ou de um sal, éster ou metabolito farmaceuticamente aceitável do mesmo
AU1711197A (en) Method for treating sexual dysfunctions
ES2106531T3 (es) Compuestos de dibenzoxazepina substituidos en 2, 3, 4, 5, 6, 7, 8, 9 y/o 10, composiciones farmaceuticas y metodos de uso.
DE69802113D1 (de) Zusammensetzungen zur erhöhung der konzentration und/oder beweglichkeit von samenzellen in menschen
ATE338553T1 (de) Antitumorkombination aus 3-amino-1,2,4- benzotriazine 1,4-dioxid/paclitaxel/platin
EP1294375A4 (en) METHOD FOR THE TREATMENT OF SEBORRHOIC DERMATITIS
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
BRPI0406634A (pt) Uso de um anagrelìdeo, anagrelìdeo na forma de base, ou um sal farmaceuticamente aceitável do anagrelìdeo, composição farmacêutica não-oral, e dispositivo médido para administração transdérmica
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
MD960168A (ro) Metodă şi compuşi pentru tratamentul infecţiilor virale
NZ326345A (en) Composition containing diosgenin
AU4370900A (en) Treatment of systemic lupus erythematosis

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/4174, A61K 9/02, A61P 15/02, A61P 31/10

Ipc: A61K 31/00 (2007.10)

B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.